TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY ANTI-hLIF ANTIBODIES

• 收藏
• 分享

专利权人:

发明人:

Frank MCCORMICK,Man-Tzu WANG

申请号：

US15508036

公开号：

US20170247446A1

申请日:

2015.09.10

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention provides method of treating a K-Ras-expressing cancer in a subject comprising administering to the subject a therapeutic amount of an agent that antagonizes leukemia inhibitory factor (LIF). Compositions and kits for treating a K-Ras-expressing cancer in a subject are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/